Legend Biotech Corporation (LEGN) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Legend Biotech Corporation (LEGN) Bundle
Enhance your investment strategies with the Legend Biotech Corporation (LEGN) DCF Calculator! Utilize authentic financial data from Legend Biotech, adjust growth projections and expenses, and instantly observe how these modifications influence the intrinsic value of (LEGN).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57.3 | 75.7 | 89.8 | 117.0 | 285.1 | 414.3 | 601.8 | 874.3 | 1,270.2 | 1,845.3 |
| Revenue Growth, % | 0 | 32.15 | 18.65 | 30.31 | 143.7 | 45.28 | 45.28 | 45.28 | 45.28 | 45.28 |
| EBITDA | -124.9 | -294.1 | -392.4 | -416.5 | -477.9 | -414.3 | -601.8 | -874.3 | -1,270.2 | -1,845.3 |
| EBITDA, % | -218.09 | -388.69 | -436.99 | -356 | -167.59 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 5.3 | 9.9 | 13.9 | 18.4 | 20.5 | 50.3 | 73.1 | 106.1 | 154.2 | 224.0 |
| Depreciation, % | 9.19 | 13.13 | 15.5 | 15.72 | 7.17 | 12.14 | 12.14 | 12.14 | 12.14 | 12.14 |
| EBIT | -130.1 | -304.1 | -406.3 | -434.9 | -498.3 | -414.3 | -601.8 | -874.3 | -1,270.2 | -1,845.3 |
| EBIT, % | -227.28 | -401.81 | -452.49 | -371.72 | -174.76 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 158.9 | 505.7 | 882.4 | 1,025.7 | 1,308.7 | 414.3 | 601.8 | 874.3 | 1,270.2 | 1,845.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 35.8 | 75.6 | 50.5 | 45.5 | 157.1 | 259.0 | 376.3 | 546.6 | 794.1 | 1,153.7 |
| Account Receivables, % | 62.44 | 99.92 | 56.25 | 38.9 | 55.08 | 62.52 | 62.52 | 62.52 | 62.52 | 62.52 |
| Inventories | 1.2 | 1.8 | 1.7 | 10.4 | 19.4 | 18.2 | 26.5 | 38.5 | 55.9 | 81.2 |
| Inventories, % | 2.02 | 2.38 | 1.95 | 8.85 | 6.82 | 4.4 | 4.4 | 4.4 | 4.4 | 4.4 |
| Accounts Payable | 9.6 | 4.9 | 7.0 | 32.9 | 20.2 | 54.9 | 79.7 | 115.9 | 168.3 | 244.5 |
| Accounts Payable, % | 16.74 | 6.49 | 7.84 | 28.11 | 7.07 | 13.25 | 13.25 | 13.25 | 13.25 | 13.25 |
| Capital Expenditure | -39.2 | -49.8 | -47.1 | -22.3 | -22.7 | -177.0 | -257.2 | -373.6 | -542.8 | -788.5 |
| Capital Expenditure, % | -68.4 | -65.78 | -52.47 | -19.04 | -7.97 | -42.73 | -42.73 | -42.73 | -42.73 | -42.73 |
| Tax Rate, % | 0.35838 | 0.35838 | 0.35838 | 0.35838 | 0.35838 | 0.35838 | 0.35838 | 0.35838 | 0.35838 | 0.35838 |
| EBITAT | -132.7 | -300.0 | -406.3 | -435.5 | -496.5 | -412.8 | -599.8 | -871.3 | -1,265.8 | -1,839.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -194.0 | -385.0 | -412.2 | -417.2 | -632.2 | -605.5 | -884.5 | -1,285.0 | -1,866.8 | -2,712.1 |
| WACC, % | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -6,053.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -2,766 | |||||||||
| Terminal Value | -79,953 | |||||||||
| Present Terminal Value | -61,291 | |||||||||
| Enterprise Value | -67,345 | |||||||||
| Net Debt | -949 | |||||||||
| Equity Value | -66,396 | |||||||||
| Diluted Shares Outstanding, MM | 176 | |||||||||
| Equity Value Per Share | -377.07 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Legend Biotech Corporation's (LEGN) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model designed to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Data: Legend Biotech's historical financial statements and pre-filled projections.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: View Legend Biotech's intrinsic value update instantly.
- Visual Analytics: Dashboard graphs showcase valuation results and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based LEGN DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically calculates Legend Biotech’s intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation variations.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator?
- Accurate Data: Real Legend Biotech financials ensure reliable valuation results.
- Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
- Time-Saving: Pre-built calculations eliminate the need to start from scratch.
- Professional-Grade Tool: Designed for investors, analysts, and consultants.
- User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.
Who Should Use This Product?
- Investors: Gain insights and make informed decisions with a cutting-edge analysis tool tailored for biotechnology.
- Financial Analysts: Streamline your workflow with a customizable financial model specifically designed for the biotech sector.
- Consultants: Effortlessly modify the template for client reports or presentations focused on biotech investments.
- Biotech Enthusiasts: Enhance your knowledge of biotech valuation methods through practical, real-world applications.
- Educators and Students: Utilize it as an effective resource for teaching and learning in biotech finance courses.
What the Template Contains
- Pre-Filled DCF Model: Legend Biotech Corporation’s (LEGN) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Legend Biotech Corporation’s (LEGN) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.